PulseAugur
EN
LIVE 06:51:30
ENTITY Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents.

Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents.

PulseAugur coverage of Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. — every cluster mentioning Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_239447 ·

    LLMs show promise in drug discovery for small-molecule design

    Researchers are exploring the use of large language models (LLMs) for small-molecule design in drug discovery. One approach involves training LLMs on synthetic tasks that generalize to complex molecular optimization pro…